Clinic
Denver Health and Hospital Authority
Denver Health and Hospital Authority was paid $29.44M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 53% of everything it billed.
33Billing provider infoDENVER HEALTH AND HOSPITAL AUTHORITY
DENVER, CO 80219
DENVER, CO 80219
33aNPI1992161780assigned 01/08/2016
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$29.44M
24GClaims408,271
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Colorado
Rank by total paid#6 of 197
Median peer was paid$1.11M
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official AUDAIN, APRIL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 92,800 | $4.30M | |
| 2019 | 69,368 | $4.41M | |
| 2020 | 64,668 | $3.31M | |
| 2021 | 65,307 | $3.69M | |
| 2022 | 52,427 | $5.17M | |
| 2023 | 39,756 | $5.20M | |
| 2024incomplete | 23,945 | $3.35M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 53% | 147,061 | 104,248 | $15.64M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 61,439 | 47,703 | $7.35M |
| D0999 | Unspecified diagnostic procedure, by report | 4.2% | 5,522 | 4,356 | $1.25M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.6% | 9,873 | 7,211 | $1.06M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.2% | 5,093 | 3,688 | $640K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 5,535 | 3,913 | $519K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.3% | 4,593 | 3,007 | $381K |
| H0025 | Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) | 1.1% | 2,559 | 1,399 | $332K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.0% | 3,193 | 2,078 | $304K |
| 0012A | <1% | 4,321 | 4,203 | $165K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 1,906 | 1,063 | $160K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 858 | 615 | $159K |
79 more codes
| 0011A | <1% | 4,234 | $142K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,591 | $140K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,805 | $114K |
| G0467 | Community health center visit, returning patient | <1% | 8,420 | $103K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 840 | $69K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 211 | $63K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 510 | $57K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 1,171 | $53K |
| D1206 | Topical application of fluoride varnish | <1% | 2,218 | $50K |
| D1120 | Dental cleaning, child | <1% | 1,195 | $45K |
| D0120 | Dental checkup, returning patient | <1% | 1,511 | $43K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 380 | $40K |
| D0330 | Panoramic radiographic image | <1% | 694 | $38K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 275 | $36K |
| 0002A | <1% | 733 | $35K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 47,855 | $34K |
| 0124A | <1% | 659 | $34K | |
| 0064A | <1% | 1,054 | $31K | |
| 0001A | <1% | 669 | $29K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 180 | $28K |
| 0071A | <1% | 462 | $21K | |
| 0072A | <1% | 338 | $20K | |
| D0272 | Bitewings - two radiographic images | <1% | 750 | $20K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 170 | $19K |
| D1110 | Prophylaxis - adult | <1% | 320 | $19K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 1,127 | $17K |
| 11982 | <1% | 122 | $17K | |
| 90480 | <1% | 501 | $16K | |
| D1351 | Sealant - per tooth | <1% | 411 | $16K |
| D0140 | Limited oral evaluation - problem focused | <1% | 449 | $13K |
| D0274 | Bitewings - four radiographic images | <1% | 282 | $12K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 2,181 | $11K |
| 58300 | <1% | 59 | $10K | |
| 0031A | <1% | 292 | $10K | |
| 0054A | <1% | 316 | $9K | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | <1% | 166 | $8K |
| H0001 | Alcohol and/or drug assessment | <1% | 68 | $8K |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 513 | $7K |
| 20610 | <1% | 136 | $6K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 12 | $5K |
| 0004A | <1% | 196 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 27 | $4K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 14 | $3K |
| 0013A | <1% | 87 | $3K | |
| H0031 | Mental health assessment, by non-physician | <1% | 87 | $3K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 41 | $3K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 23 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 40,290 | $2K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 627 | $2K |
| 0052A | <1% | 35 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 751 | $1K |
| 91322 | <1% | 12 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 30 | $726.39 |
| 36416 | <1% | 1,230 | $695.11 | |
| 0111A | <1% | 12 | $679.47 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 13,725 | $654.89 |
| 0051A | <1% | 12 | $617.70 | |
| 90688 | <1% | 5,518 | $198.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 359 | $71.36 |
| 90677 | <1% | 13 | $35.28 | |
| D0270 | <1% | 12 | $28.00 | |
| 90686 | <1% | 459 | $23.56 | |
| 90474 | <1% | 1,290 | $6.50 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 1,186 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 259 | $0.00 |
| 90732 | 0% | 14 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 406 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 68 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 35 | $0.00 |
| 90694 | 0% | 61 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 81 | $0.00 |
| D4342 | 0% | 15 | $0.00 | |
| 99406 | 0% | 24 | $0.00 | |
| 83986 | 0% | 16 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 459 | $0.00 |
| D0190 | 0% | 726 | $0.00 | |
| 90682 | 0% | 17 | $0.00 | |
| 90715 | 0% | 209 | $0.00 | |
| 90750 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAUDAIN, APRIL (CHIEF FINANCIAL OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.